CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys
A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtain...
Gespeichert in:
Veröffentlicht in: | Journal of chemical information and modeling 2013-08, Vol.53 (8), p.1842-1852 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1852 |
---|---|
container_issue | 8 |
container_start_page | 1842 |
container_title | Journal of chemical information and modeling |
container_volume | 53 |
creator | Dunbar, James B Smith, Richard D Damm-Ganamet, Kelly L Ahmed, Aqeel Esposito, Emilio Xavier Delproposto, James Chinnaswamy, Krishnapriya Kang, You-Na Kubish, Ginger Gestwicki, Jason E Stuckey, Jeanne A Carlson, Heather A |
description | A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtained data from Abbott, GlaxoSmithKline, and Vertex and is working on obtaining data from several others. Combined with our in-house projects, we are providing a data set consisting of 6 protein targets, 647 compounds with biological affinities, and 82 crystal structures. Multiple congeneric series are available for several targets with a few representative crystal structures of each of the series. These series generally contain a few inactive compounds, usually not available in the literature, to provide an upper bound to the affinity range. The affinity ranges are typically 3–4 orders of magnitude per series. For our in-house projects, we have had compounds synthesized for biological testing. Affinities were measured by Thermofluor, Octet RED, and isothermal titration calorimetry for the most soluble. This allows the direct comparison of the biological affinities for those compounds, providing a measure of the variance in the experimental affinity. It appears that there can be considerable variance in the absolute value of the affinity, making the prediction of the absolute value ill-defined. However, the relative rankings within the methods are much better, and this fits with the observation that predicting relative ranking is a more tractable problem computationally. For those in-house compounds, we also have measured the following physical properties: logD, logP, thermodynamic solubility, and pK a. This data set also provides a substantial decoy set for each target consisting of diverse conformations covering the entire active site for all of the 58 CSAR-quality crystal structures. The CSAR data sets (CSAR-NRC HiQ and the 2012 release) provide substantial, publically available, curated data sets for use in parametrizing and validating docking and scoring methods. |
doi_str_mv | 10.1021/ci4000486 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3753885</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3059453721</sourcerecordid><originalsourceid>FETCH-LOGICAL-a562t-ee4ea1171b8b8169be9b34ea3b58ac07d3b739c2abfa614a042873d6261f7e9f3</originalsourceid><addsrcrecordid>eNqFkd1LHDEUxUOx1I_2wX9ABkRoodvmY5JMfCgsu9oWFgU_wLdwJ3tnjc5O1sms1P_erK6r1gefcsj9cXJuDiHbjP5glLOfzueU0rxQH8gGk7npGUUv1p60NGqdbMZ4RakQRvFPZJ0LxTTneoMcDU77J9kQOshOsctOsEaImHHK-H428hNoxvF71q8q3_jOY9KDMJ3V-G8h0zAbBnftm0k2RBfu4mfysYI64pfluUXODw_OBn96o-Pffwf9UQ-k4l0PMUdgTLOyKAumTImmFOlKlLIAR_VYlFoYx6GsQLEcaM4LLcaKK1ZpNJXYIr8efWfzcopjh03XQm1nrZ9Ce2cDePt60vhLOwm3VmgpikImg69LgzbczDF2duqjw7qGBsM8WpY4SSVX6n00heOaM2ESuvsfehXmbZN-4oEyMhWyoL49Uq4NMbZYrXIzaheF2lWhid15ueiKfGowAXtLAKKDumqhcT4-c1qlcEY-c-Dii1RvHrwH5t2wdg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1428955499</pqid></control><display><type>article</type><title>CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys</title><source>ACS Publications</source><source>MEDLINE</source><creator>Dunbar, James B ; Smith, Richard D ; Damm-Ganamet, Kelly L ; Ahmed, Aqeel ; Esposito, Emilio Xavier ; Delproposto, James ; Chinnaswamy, Krishnapriya ; Kang, You-Na ; Kubish, Ginger ; Gestwicki, Jason E ; Stuckey, Jeanne A ; Carlson, Heather A</creator><creatorcontrib>Dunbar, James B ; Smith, Richard D ; Damm-Ganamet, Kelly L ; Ahmed, Aqeel ; Esposito, Emilio Xavier ; Delproposto, James ; Chinnaswamy, Krishnapriya ; Kang, You-Na ; Kubish, Ginger ; Gestwicki, Jason E ; Stuckey, Jeanne A ; Carlson, Heather A</creatorcontrib><description>A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtained data from Abbott, GlaxoSmithKline, and Vertex and is working on obtaining data from several others. Combined with our in-house projects, we are providing a data set consisting of 6 protein targets, 647 compounds with biological affinities, and 82 crystal structures. Multiple congeneric series are available for several targets with a few representative crystal structures of each of the series. These series generally contain a few inactive compounds, usually not available in the literature, to provide an upper bound to the affinity range. The affinity ranges are typically 3–4 orders of magnitude per series. For our in-house projects, we have had compounds synthesized for biological testing. Affinities were measured by Thermofluor, Octet RED, and isothermal titration calorimetry for the most soluble. This allows the direct comparison of the biological affinities for those compounds, providing a measure of the variance in the experimental affinity. It appears that there can be considerable variance in the absolute value of the affinity, making the prediction of the absolute value ill-defined. However, the relative rankings within the methods are much better, and this fits with the observation that predicting relative ranking is a more tractable problem computationally. For those in-house compounds, we also have measured the following physical properties: logD, logP, thermodynamic solubility, and pK a. This data set also provides a substantial decoy set for each target consisting of diverse conformations covering the entire active site for all of the 58 CSAR-quality crystal structures. The CSAR data sets (CSAR-NRC HiQ and the 2012 release) provide substantial, publically available, curated data sets for use in parametrizing and validating docking and scoring methods.</description><identifier>ISSN: 1549-9596</identifier><identifier>EISSN: 1549-960X</identifier><identifier>DOI: 10.1021/ci4000486</identifier><identifier>PMID: 23617227</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Affinity ; Biological ; Biological and medical sciences ; Chemical compounds ; Crystal structure ; Databases, Pharmaceutical ; Docking ; Drug Design ; General pharmacology ; Internet ; Ligands ; Medical sciences ; Molecular chemistry ; Molecular Docking Simulation - methods ; Molecular structure ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Physicochemical properties. Structure-activity relationships ; Protein Binding ; Protein Conformation ; Proteins ; Ranking ; Scoring ; Structure-Activity Relationship ; Thermodynamics ; Variance</subject><ispartof>Journal of chemical information and modeling, 2013-08, Vol.53 (8), p.1842-1852</ispartof><rights>Copyright © 2013 American Chemical Society</rights><rights>2014 INIST-CNRS</rights><rights>Copyright American Chemical Society Aug 26, 2013</rights><rights>Copyright © 2013 American Chemical Society 2013 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a562t-ee4ea1171b8b8169be9b34ea3b58ac07d3b739c2abfa614a042873d6261f7e9f3</citedby><cites>FETCH-LOGICAL-a562t-ee4ea1171b8b8169be9b34ea3b58ac07d3b739c2abfa614a042873d6261f7e9f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/ci4000486$$EPDF$$P50$$Gacs$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/ci4000486$$EHTML$$P50$$Gacs$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27682795$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23617227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dunbar, James B</creatorcontrib><creatorcontrib>Smith, Richard D</creatorcontrib><creatorcontrib>Damm-Ganamet, Kelly L</creatorcontrib><creatorcontrib>Ahmed, Aqeel</creatorcontrib><creatorcontrib>Esposito, Emilio Xavier</creatorcontrib><creatorcontrib>Delproposto, James</creatorcontrib><creatorcontrib>Chinnaswamy, Krishnapriya</creatorcontrib><creatorcontrib>Kang, You-Na</creatorcontrib><creatorcontrib>Kubish, Ginger</creatorcontrib><creatorcontrib>Gestwicki, Jason E</creatorcontrib><creatorcontrib>Stuckey, Jeanne A</creatorcontrib><creatorcontrib>Carlson, Heather A</creatorcontrib><title>CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys</title><title>Journal of chemical information and modeling</title><addtitle>J. Chem. Inf. Model</addtitle><description>A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtained data from Abbott, GlaxoSmithKline, and Vertex and is working on obtaining data from several others. Combined with our in-house projects, we are providing a data set consisting of 6 protein targets, 647 compounds with biological affinities, and 82 crystal structures. Multiple congeneric series are available for several targets with a few representative crystal structures of each of the series. These series generally contain a few inactive compounds, usually not available in the literature, to provide an upper bound to the affinity range. The affinity ranges are typically 3–4 orders of magnitude per series. For our in-house projects, we have had compounds synthesized for biological testing. Affinities were measured by Thermofluor, Octet RED, and isothermal titration calorimetry for the most soluble. This allows the direct comparison of the biological affinities for those compounds, providing a measure of the variance in the experimental affinity. It appears that there can be considerable variance in the absolute value of the affinity, making the prediction of the absolute value ill-defined. However, the relative rankings within the methods are much better, and this fits with the observation that predicting relative ranking is a more tractable problem computationally. For those in-house compounds, we also have measured the following physical properties: logD, logP, thermodynamic solubility, and pK a. This data set also provides a substantial decoy set for each target consisting of diverse conformations covering the entire active site for all of the 58 CSAR-quality crystal structures. The CSAR data sets (CSAR-NRC HiQ and the 2012 release) provide substantial, publically available, curated data sets for use in parametrizing and validating docking and scoring methods.</description><subject>Affinity</subject><subject>Biological</subject><subject>Biological and medical sciences</subject><subject>Chemical compounds</subject><subject>Crystal structure</subject><subject>Databases, Pharmaceutical</subject><subject>Docking</subject><subject>Drug Design</subject><subject>General pharmacology</subject><subject>Internet</subject><subject>Ligands</subject><subject>Medical sciences</subject><subject>Molecular chemistry</subject><subject>Molecular Docking Simulation - methods</subject><subject>Molecular structure</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Physicochemical properties. Structure-activity relationships</subject><subject>Protein Binding</subject><subject>Protein Conformation</subject><subject>Proteins</subject><subject>Ranking</subject><subject>Scoring</subject><subject>Structure-Activity Relationship</subject><subject>Thermodynamics</subject><subject>Variance</subject><issn>1549-9596</issn><issn>1549-960X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>N~.</sourceid><sourceid>EIF</sourceid><recordid>eNqFkd1LHDEUxUOx1I_2wX9ABkRoodvmY5JMfCgsu9oWFgU_wLdwJ3tnjc5O1sms1P_erK6r1gefcsj9cXJuDiHbjP5glLOfzueU0rxQH8gGk7npGUUv1p60NGqdbMZ4RakQRvFPZJ0LxTTneoMcDU77J9kQOshOsctOsEaImHHK-H428hNoxvF71q8q3_jOY9KDMJ3V-G8h0zAbBnftm0k2RBfu4mfysYI64pfluUXODw_OBn96o-Pffwf9UQ-k4l0PMUdgTLOyKAumTImmFOlKlLIAR_VYlFoYx6GsQLEcaM4LLcaKK1ZpNJXYIr8efWfzcopjh03XQm1nrZ9Ce2cDePt60vhLOwm3VmgpikImg69LgzbczDF2duqjw7qGBsM8WpY4SSVX6n00heOaM2ESuvsfehXmbZN-4oEyMhWyoL49Uq4NMbZYrXIzaheF2lWhid15ueiKfGowAXtLAKKDumqhcT4-c1qlcEY-c-Dii1RvHrwH5t2wdg</recordid><startdate>20130826</startdate><enddate>20130826</enddate><creator>Dunbar, James B</creator><creator>Smith, Richard D</creator><creator>Damm-Ganamet, Kelly L</creator><creator>Ahmed, Aqeel</creator><creator>Esposito, Emilio Xavier</creator><creator>Delproposto, James</creator><creator>Chinnaswamy, Krishnapriya</creator><creator>Kang, You-Na</creator><creator>Kubish, Ginger</creator><creator>Gestwicki, Jason E</creator><creator>Stuckey, Jeanne A</creator><creator>Carlson, Heather A</creator><general>American Chemical Society</general><scope>N~.</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SC</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>JQ2</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130826</creationdate><title>CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys</title><author>Dunbar, James B ; Smith, Richard D ; Damm-Ganamet, Kelly L ; Ahmed, Aqeel ; Esposito, Emilio Xavier ; Delproposto, James ; Chinnaswamy, Krishnapriya ; Kang, You-Na ; Kubish, Ginger ; Gestwicki, Jason E ; Stuckey, Jeanne A ; Carlson, Heather A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a562t-ee4ea1171b8b8169be9b34ea3b58ac07d3b739c2abfa614a042873d6261f7e9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Affinity</topic><topic>Biological</topic><topic>Biological and medical sciences</topic><topic>Chemical compounds</topic><topic>Crystal structure</topic><topic>Databases, Pharmaceutical</topic><topic>Docking</topic><topic>Drug Design</topic><topic>General pharmacology</topic><topic>Internet</topic><topic>Ligands</topic><topic>Medical sciences</topic><topic>Molecular chemistry</topic><topic>Molecular Docking Simulation - methods</topic><topic>Molecular structure</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Physicochemical properties. Structure-activity relationships</topic><topic>Protein Binding</topic><topic>Protein Conformation</topic><topic>Proteins</topic><topic>Ranking</topic><topic>Scoring</topic><topic>Structure-Activity Relationship</topic><topic>Thermodynamics</topic><topic>Variance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dunbar, James B</creatorcontrib><creatorcontrib>Smith, Richard D</creatorcontrib><creatorcontrib>Damm-Ganamet, Kelly L</creatorcontrib><creatorcontrib>Ahmed, Aqeel</creatorcontrib><creatorcontrib>Esposito, Emilio Xavier</creatorcontrib><creatorcontrib>Delproposto, James</creatorcontrib><creatorcontrib>Chinnaswamy, Krishnapriya</creatorcontrib><creatorcontrib>Kang, You-Na</creatorcontrib><creatorcontrib>Kubish, Ginger</creatorcontrib><creatorcontrib>Gestwicki, Jason E</creatorcontrib><creatorcontrib>Stuckey, Jeanne A</creatorcontrib><creatorcontrib>Carlson, Heather A</creatorcontrib><collection>American Chemical Society (ACS) Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Computer and Information Systems Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of chemical information and modeling</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dunbar, James B</au><au>Smith, Richard D</au><au>Damm-Ganamet, Kelly L</au><au>Ahmed, Aqeel</au><au>Esposito, Emilio Xavier</au><au>Delproposto, James</au><au>Chinnaswamy, Krishnapriya</au><au>Kang, You-Na</au><au>Kubish, Ginger</au><au>Gestwicki, Jason E</au><au>Stuckey, Jeanne A</au><au>Carlson, Heather A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys</atitle><jtitle>Journal of chemical information and modeling</jtitle><addtitle>J. Chem. Inf. Model</addtitle><date>2013-08-26</date><risdate>2013</risdate><volume>53</volume><issue>8</issue><spage>1842</spage><epage>1852</epage><pages>1842-1852</pages><issn>1549-9596</issn><eissn>1549-960X</eissn><abstract>A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtained data from Abbott, GlaxoSmithKline, and Vertex and is working on obtaining data from several others. Combined with our in-house projects, we are providing a data set consisting of 6 protein targets, 647 compounds with biological affinities, and 82 crystal structures. Multiple congeneric series are available for several targets with a few representative crystal structures of each of the series. These series generally contain a few inactive compounds, usually not available in the literature, to provide an upper bound to the affinity range. The affinity ranges are typically 3–4 orders of magnitude per series. For our in-house projects, we have had compounds synthesized for biological testing. Affinities were measured by Thermofluor, Octet RED, and isothermal titration calorimetry for the most soluble. This allows the direct comparison of the biological affinities for those compounds, providing a measure of the variance in the experimental affinity. It appears that there can be considerable variance in the absolute value of the affinity, making the prediction of the absolute value ill-defined. However, the relative rankings within the methods are much better, and this fits with the observation that predicting relative ranking is a more tractable problem computationally. For those in-house compounds, we also have measured the following physical properties: logD, logP, thermodynamic solubility, and pK a. This data set also provides a substantial decoy set for each target consisting of diverse conformations covering the entire active site for all of the 58 CSAR-quality crystal structures. The CSAR data sets (CSAR-NRC HiQ and the 2012 release) provide substantial, publically available, curated data sets for use in parametrizing and validating docking and scoring methods.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>23617227</pmid><doi>10.1021/ci4000486</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1549-9596 |
ispartof | Journal of chemical information and modeling, 2013-08, Vol.53 (8), p.1842-1852 |
issn | 1549-9596 1549-960X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3753885 |
source | ACS Publications; MEDLINE |
subjects | Affinity Biological Biological and medical sciences Chemical compounds Crystal structure Databases, Pharmaceutical Docking Drug Design General pharmacology Internet Ligands Medical sciences Molecular chemistry Molecular Docking Simulation - methods Molecular structure Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Physicochemical properties. Structure-activity relationships Protein Binding Protein Conformation Proteins Ranking Scoring Structure-Activity Relationship Thermodynamics Variance |
title | CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T17%3A23%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CSAR%20Data%20Set%20Release%202012:%20Ligands,%20Affinities,%20Complexes,%20and%20Docking%20Decoys&rft.jtitle=Journal%20of%20chemical%20information%20and%20modeling&rft.au=Dunbar,%20James%20B&rft.date=2013-08-26&rft.volume=53&rft.issue=8&rft.spage=1842&rft.epage=1852&rft.pages=1842-1852&rft.issn=1549-9596&rft.eissn=1549-960X&rft_id=info:doi/10.1021/ci4000486&rft_dat=%3Cproquest_pubme%3E3059453721%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1428955499&rft_id=info:pmid/23617227&rfr_iscdi=true |